Works matching IS 00070920 AND DT 2012 AND VI 106 AND IP 8

Results: 20

Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.

Published in:

2012

By:

Oliveras-Ferraros C;
Cufí S;
Queralt B;
Vazquez-Martin A;
Martin-Castillo B;
de Llorens R;
Bosch-Barrera J;
Brunet J;
Menendez JA;
Oliveras-Ferraros, C;
Cufí, S;
Queralt, B;
Vazquez-Martin, A;
Martin-Castillo, B;
de Llorens, R;
Bosch-Barrera, J;
Brunet, J;
Menendez, J A

Publication type:

journal article

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer.

Published in:

2012

By:

Ohotski J;
Long JS;
Orange C;
Elsberger B;
Mallon E;
Doughty J;
Pyne S;
Pyne NJ;
Edwards J;
Ohotski, J;
Long, J S;
Orange, C;
Elsberger, B;
Mallon, E;
Doughty, J;
Pyne, S;
Pyne, N J;
Edwards, J

Publication type:

journal article

Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells.

Published in:

2012

By:

Stein U;
Fleuter C;
Siegel F;
Smith J;
Kopacek A;
Scudiero DA;
Hite KM;
Schlag PM;
Shoemaker RH;
Walther W;
Stein, U;
Fleuter, C;
Siegel, F;
Smith, J;
Kopacek, A;
Scudiero, D A;
Hite, K M;
Schlag, P M;
Shoemaker, R H;
Walther, W

Publication type:

journal article

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI).

Published in:

2012

By:

Pinato DJ;
North BV;
Sharma R;
Pinato, D J;
North, B V;
Sharma, R

Publication type:

journal article

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1453, doi. 10.1038/bjc.2012.98

By:

Ohotski, J;
Long, J S;
Orange, C;
Elsberger, B;
Mallon, E;
Doughty, J;
Pyne, S;
Pyne, N J;
Edwards, J

Publication type:

Article

Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1406, doi. 10.1038/bjc.2012.103

By:

Oliveras-Ferraros, C;
Cufí, S;
Queralt, B;
Vazquez-Martin, A;
Martin-Castillo, B;
de Llorens, R;
Bosch-Barrera, J;
Brunet, J;
Menendez, J A

Publication type:

Article

Major ethnic group differences in breast cancer screening uptake in Scotland are not extinguished by adjustment for indices of geographical residence, area deprivation, long-term illness and education.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1361, doi. 10.1038/bjc.2012.83

By:

Bansal, N;
Bhopal, R S;
Steiner, M F C;
Brewster, D H

Publication type:

Article

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI).

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1439, doi. 10.1038/bjc.2012.92

By:

Pinato, D J;
North, B V;
Sharma, R

Publication type:

Article

Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1424, doi. 10.1038/bjc.2012.104

By:

Tao, S;
Haug, U;
Kuhn, K;
Brenner, H

Publication type:

Article

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1460, doi. 10.1038/bjc.2012.87

By:

Osher, D J;
De Leeneer, K;
Michils, G;
Hamel, N;
Tomiak, E;
Poppe, B;
Leunen, K;
Legius, E;
Shuen, A;
Smith, E;
Arseneau, J;
Tonin, P;
Matthijs, G;
Claes, K;
Tischkowitz, M D;
Foulkes, W D

Publication type:

Article

Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1395, doi. 10.1038/bjc.2012.81

By:

Stein, U;
Fleuter, C;
Siegel, F;
Smith, J;
Kopacek, A;
Scudiero, D A;
Hite, K M;
Schlag, P M;
Shoemaker, R H;
Walther, W

Publication type:

Article

First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1379, doi. 10.1038/bjc.2012.99

By:

Yap, T A;
Cortes-Funes, H;
Shaw, H;
Rodriguez, R;
Olmos, D;
Lal, R;
Fong, P C;
Tan, D S;
Harris, D;
Capdevila, J;
Coronado, C;
Alfaro, V;
Soto-Matos, A;
Fernández-Teruel, C;
Siguero, M;
Tabernero, J M;
Paz-Ares, L;
de Bono, J S;
López-Martin, J A

Publication type:

Article

NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1446, doi. 10.1038/bjc.2012.95

By:

Wang, H;
Lee, S;
Nigro, C Lo;
Lattanzio, L;
Merlano, M;
Monteverde, M;
Matin, R;
Purdie, K;
Mladkova, N;
Bergamaschi, D;
Harwood, C;
Syed, N;
Szlosarek, P;
Briasoulis, E;
McHugh, A;
Thompson, A;
Evans, A;
Leigh, I;
Fleming, C;
Inman, G J

Publication type:

Article

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1367, doi. 10.1038/bjc.2012.85

By:

Gallardo, A;
Lerma, E;
Escuin, D;
Tibau, A;
Muñoz, J;
Ojeda, B;
Barnadas, A;
Adrover, E;
Sánchez-Tejada, L;
Giner, D;
Ortiz-Martínez, F;
Peiró, G

Publication type:

Article

High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1415, doi. 10.1038/bjc.2012.90

By:

Hamano, R;
Miyata, H;
Yamasaki, M;
Sugimura, K;
Tanaka, K;
Kurokawa, Y;
Nakajima, K;
Takiguchi, S;
Fujiwara, Y;
Mori, M;
Doki, Y

Publication type:

Article

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1374, doi. 10.1038/bjc.2012.71

By:

Garrett, C R;
Hassabo, H M;
Bhadkamkar, N A;
Wen, S;
Baladandayuthapani, V;
Kee, B K;
Eng, C;
Hassan, M M

Publication type:

Article

The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1386, doi. 10.1038/bjc.2012.70

By:

Haagensen, E J;
Kyle, S;
Beale, G S;
Maxwell, R J;
Newell, D R

Publication type:

Article

Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1431, doi. 10.1038/bjc.2012.93

By:

Wilson, S;
Damery, S;
Stocken, D D;
Dowswell, G;
Holder, R;
Ward, S T;
Redman, V;
Wakelam, M J;
James, J;
Hobbs, F D R;
Ismail, T

Publication type:

Article

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1466, doi. 10.1038/bjc.2012.79

By:

Khan, O A;
Blann, A D;
Payne, M J;
Middleton, M R;
Protheroe, A S;
Talbot, D C;
Taylor, M;
Han, C;
Patil, M;
Harris, A L

Publication type:

Article

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate.

Published in:

British Journal of Cancer, 2012, v. 106, n. 8, p. 1464, doi. 10.1038/bjc.2012.78

By:

Dickinson, P D;
Peel, D N Y;
Sundar, S

Publication type:

Article